Abstract
Objective
Hemangiomas are the most common benign soft tissue tumors occurring in 5–10 % of children at around the age of 1 year and of them 10 % are associated with significant morbidity and entail medical attention. In this study, efficacy and adverse effects of the drug propranolol were observed on hemangiomas.
Methods
Oral propranolol was given to 36 children at a dose of 3 mg/kg/day in three divided doses. Blood pressure and heart rate were recorded during the first 3 h of treatment. Treatment was continued at home and the children were re-evaluated at monthly interval. Photographs were taken in pre- and post-treatment phages and changes of hemangiomas were measured with visual analog scale.
Results
Immediate effects on color and growth were noted in all cases that were especially dramatic in cases of extensive lesions. Clinical evidence of regression was seen within 30 days in all cases and completely regressed within 7 months. Mean duration of treatment was 4.1 months.
Conclusion
Propranolol had a rapid stabilizing effect leading to early regression of hemangiomas when administered orally at a dose of 3 mg/kg/day with good quality safety profile.
Similar content being viewed by others
References
Bennett HAB, Denise WM, Eulalia B, Anne WL, Denise MA, Maria RC, Ilona JF (2008) Infantile hemangiomas with unusually prolonged growth phase—a case series. Arch Dermatol 144:1632–1637. http.www.archdermatol.com
Christine LL, Eric DR, Thomas H, Franck B, Jean BT, Alain T (2010) Propranolol for severe hemangiomas of infancy. N Engl J Med 358(24):2649–2651. http://www.nejm.org
Hoque S, Das BK, Abid R (2011) Vascular anomalies in children. Asian Color Printer, Bangladesh
Sans V, Roque ED, Berge J, Grenier N, Boralevi F, Hautier JM, Lipsker D, Dupuis E, Ezzedine K, Vergnes V, Taïeb A, Labrèze CL (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:e423–e431. http://www.pediatrics.org/cgi/content/full/124/3/e423
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasan, M., Rahman, M., Hoque, S. et al. Propranolol for hemangiomas. Pediatr Surg Int 29, 257–262 (2013). https://doi.org/10.1007/s00383-012-3220-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-012-3220-5